首页> 外国专利> Diagnostic assay for breast cancer susceptibility

Diagnostic assay for breast cancer susceptibility

机译:乳腺癌易感性诊断分析

摘要

The lifetime probability of a woman developing breast cancer can now be determined based on an allelic variation found in the 3′UTR of the prohibitin gene. The probability is dependent on the sequence of the 3′UTR at position 729, i.e., whether there is a thymine (T) or a cytosine (C) or both at this position. Polymorphism at position 729 is also disclosed as a susceptibility indicator for hereditary breast cancer in men. Determining the sequence at the position 729 can be done by any number of standard techniques. Preferably, the sequence is determined by amplifying this region by PCR and subjecting it to an RFLP analysis.
机译:现在可以根据在禁止素基因的3′UTR中发现的等位基因变异来确定女性患乳腺癌的终生可能性。概率取决于在位置729处3′primer的序列,即在该位置处是否存在胸腺嘧啶(T)或胞嘧啶(C)或两者。还公开了位置729处的多态性作为男性遗传性乳腺癌的敏感性指标。可以通过许多标准技术来确定在位置729处的顺序。优选地,通过PCR扩增该区域并对其进行RFLP分析来确定序列。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号